SI2173337T1 - Fosfaplatini in njihova uporaba pri zdravljenju vrst raka, odpornih proti cisplatinu in karboplatinu - Google Patents

Fosfaplatini in njihova uporaba pri zdravljenju vrst raka, odpornih proti cisplatinu in karboplatinu

Info

Publication number
SI2173337T1
SI2173337T1 SI200831280T SI200831280T SI2173337T1 SI 2173337 T1 SI2173337 T1 SI 2173337T1 SI 200831280 T SI200831280 T SI 200831280T SI 200831280 T SI200831280 T SI 200831280T SI 2173337 T1 SI2173337 T1 SI 2173337T1
Authority
SI
Slovenia
Prior art keywords
phosphaplatins
cisplantin
carboplatin
treatment
cancers resistant
Prior art date
Application number
SI200831280T
Other languages
English (en)
Inventor
Rathindra N. Bose
Original Assignee
Ohio University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ohio University filed Critical Ohio University
Publication of SI2173337T1 publication Critical patent/SI2173337T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI200831280T 2007-08-06 2008-08-06 Fosfaplatini in njihova uporaba pri zdravljenju vrst raka, odpornih proti cisplatinu in karboplatinu SI2173337T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US95412607P 2007-08-06 2007-08-06
US97392607P 2007-09-20 2007-09-20
EP08797320.2A EP2173337B1 (en) 2007-08-06 2008-08-06 Phosphaplatins and their use in the treatment of cancers resistant to cisplantin and carboplatin
PCT/US2008/072398 WO2009021082A2 (en) 2007-08-06 2008-08-06 Phosphaplatins and their use in the treatment of cancers resistant to cisplantin and carboplatin

Publications (1)

Publication Number Publication Date
SI2173337T1 true SI2173337T1 (sl) 2014-10-30

Family

ID=40342030

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200831280T SI2173337T1 (sl) 2007-08-06 2008-08-06 Fosfaplatini in njihova uporaba pri zdravljenju vrst raka, odpornih proti cisplatinu in karboplatinu

Country Status (13)

Country Link
US (4) US7700649B2 (sl)
EP (2) EP2668949A1 (sl)
JP (2) JP5385274B2 (sl)
CN (1) CN101801369B (sl)
CY (1) CY1115504T1 (sl)
DK (1) DK2173337T3 (sl)
ES (1) ES2495743T3 (sl)
HK (1) HK1143551A1 (sl)
HR (1) HRP20140808T1 (sl)
PL (1) PL2173337T3 (sl)
PT (1) PT2173337E (sl)
SI (1) SI2173337T1 (sl)
WO (2) WO2009021082A2 (sl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2173337E (pt) 2007-08-06 2014-09-03 Univ Ohio Fosfoplatinas e a sua utilização no tratamento de cancros resistentes à cisplantina e carboplatina
AP3480A (en) * 2010-06-04 2015-12-31 Univ Ohio Phosphaplatins and their use for treatment of cancers
WO2012096722A1 (en) 2011-01-12 2012-07-19 Ohio University Phosphaplatins having anti-angiogenic, anti-metastatic, and pro-apoptotic properties and uses thereof
MX354678B (es) 2011-07-08 2018-03-15 Dow Global Technologies Llc Composicion de mezcla de polietileno adecuada para pelicula soplada, metodo para producir la misma y peliculas hechas a partir de la misma.
CN104010508B (zh) * 2011-10-05 2017-03-15 理辛德拉·N·博斯 用于大规模制备磷铂类抗肿瘤剂的高效方法
MX357865B (es) 2011-10-05 2018-07-25 N Bose Rathindra Procedimientos eficientes para preparación a gran escala de agentes antitumorales de fosfaplatinos.
JP6255346B2 (ja) 2011-10-20 2017-12-27 ネリウム バイオテクノロジー，インコーポレーテッド 癌治療のための治療用組合せ
PL3202769T3 (pl) 2012-05-24 2020-03-31 Phosplatin Therapeutics Llc Sposoby oczyszczania związków fosfaplatyny
US9333211B2 (en) * 2013-02-22 2016-05-10 University Of Houston System Phosphaplatin mediated modulation of pigment epithelial derived factor and uses thereof
WO2015127037A1 (en) * 2014-02-19 2015-08-27 University Of Houston System Compositions and methods for the treatment of neurodegenerative diseases
CA2950305C (en) 2014-06-11 2023-03-14 Board Of Regents, The University Of Texas System Texaphyrin-pt(iv) conjugates and compositions for use in overcoming platinum resistance
WO2017116356A1 (en) 2015-12-30 2017-07-06 Atilim Universitesi Dna targeted mono and heterodinuclear complexes
JP7023968B2 (ja) * 2017-01-06 2022-02-22 フォスプラティン・セラピューティクス・インコーポレーテッド 骨がんまたは血液がんの治療のための治療薬としてのホスファプラチン化合物
CN111328330B (zh) * 2017-09-08 2024-03-08 普罗蒙托里治疗有限公司 作为免疫调节剂的磷铂化合物及其治疗用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234500A (en) * 1979-03-07 1980-11-18 Engelhard Minerals & Chemicals Corporation Ethylenediamine platinum(II) and 1,2-diamino-cyclohexane platinum(II) pyrophosphate complexes
US4291027A (en) 1979-03-07 1981-09-22 Engelhard Minerals & Chemicals Corp. Method for treating tumors with ethylenediamine platinum (II) and 1,2-diaminocyclohexane-platinum (II) pyrophosphate complexes
CA2017739A1 (en) * 1989-07-18 1991-01-18 Leslie S. Hollis Cis-diamineplatinum complexes with methanediphosphonate and substituted methanediphosphonate ligands as antitumor agents
JP4463274B2 (ja) 2003-06-27 2010-05-19 明 小谷 ビスホスホネート錯体
WO2009008345A1 (ja) * 2007-07-06 2009-01-15 Tmrc Co., Ltd. 金属錯体化合物、これを有効成分とする癌治療剤組成物および該金属錯体化合物用の中間体
PT2173337E (pt) * 2007-08-06 2014-09-03 Univ Ohio Fosfoplatinas e a sua utilização no tratamento de cancros resistentes à cisplantina e carboplatina

Also Published As

Publication number Publication date
US20130237503A1 (en) 2013-09-12
PL2173337T3 (pl) 2014-11-28
PT2173337E (pt) 2014-09-03
US8445710B2 (en) 2013-05-21
US20090042838A1 (en) 2009-02-12
JP5647300B2 (ja) 2014-12-24
US20110313182A1 (en) 2011-12-22
CN101801369A (zh) 2010-08-11
US8653132B2 (en) 2014-02-18
CN101801369B (zh) 2012-09-19
WO2009021081A2 (en) 2009-02-12
WO2009021081A3 (en) 2009-05-07
WO2009021082A3 (en) 2009-04-23
US20100233293A1 (en) 2010-09-16
EP2173337A2 (en) 2010-04-14
CY1115504T1 (el) 2017-01-04
JP2013227218A (ja) 2013-11-07
EP2173337A4 (en) 2010-10-27
DK2173337T3 (da) 2014-09-15
EP2668949A1 (en) 2013-12-04
JP2010535803A (ja) 2010-11-25
WO2009021082A2 (en) 2009-02-12
ES2495743T3 (es) 2014-09-17
US8034964B2 (en) 2011-10-11
HRP20140808T1 (hr) 2014-10-24
US7700649B2 (en) 2010-04-20
JP5385274B2 (ja) 2014-01-08
HK1143551A1 (en) 2011-01-07
EP2173337B1 (en) 2014-07-30

Similar Documents

Publication Publication Date Title
PL2173337T3 (pl) Fosfaplatyny i ich zastosowanie w leczeniu raków opornych na cisplatynę i karboplatynę
HK1170485A1 (zh) -噻唑烷- -酮衍生物及其在癌症治療中的用途
IL234064B (en) A medical combination including trastuzumab-mcc-dm1 and docetaxel for use in the treatment of cancer expressing erbb2
ZA201109384B (en) Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
PL2601961T3 (pl) Kompozycje zawierające LAG-3 i terapeutyczne przeciwciała oraz ich zastosowania w leczeniu raka
IL201887A0 (en) Honokiol analogs and their use in treating cancers
ZA201201434B (en) Use of metformin in cancer treatment and prevention
HK1136822A1 (en) Therapeutic compounds and their use in cancer
PL2483278T3 (pl) Związki benzoksazepinowe stanowiące inhibitor pi3k i ich zastosowanie w leczeniu nowotworu
EP2237785A4 (en) TRIARYLMETHANE ANALOGUE AND ITS USE IN CANCER TREATMENT
ZA200907245B (en) Phthalazinone derivatives and their use as medicament to treat cancer
PT2101731T (pt) Endoxifeno para utilização no tratamento de cancro
HK1209053A1 (zh) 地來西坦在慢性疼痛的治療中的用途
EP2148666A4 (en) Fulvic and fulvalal analogs and their use in cancer treatment
IL201426A0 (en) Drug combination and its use in the treatment of muscle loss
PL2320900T3 (pl) Opioidy do zastosowania w leczeniu opornych pacjentów onkologicznych
GB0704982D0 (en) Improvements in or relating to photodynamic therapy
ZA201202657B (en) Use of the sparc microenvironment signature in the treatment of cancer
GB0819103D0 (en) Raphaine compounds and their use in therapy
GB0610046D0 (en) Materials and methods relating to the diagnosis and treatment of cancer
GB0722338D0 (en) Novel use and treatment
HUP1000688A2 (en) Use of trifluoro-phthalimides in the treatment of cancer